skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: PBF/BNCT Program for cancer treatment

Technical Report ·
DOI:https://doi.org/10.2172/7018387· OSTI ID:7018387

Highlights of the PBF/BNCT Program during August included: gross boron analysis in tissue, blood, and urine (biological samples for boron analysis were received from WSU, including samples from five p-BPA/melanoma dogs and seven BSH plasmapheresis dogs); analytical methodologies development for BSH (borocaptate sodium) purity determination (much effort this month focussed on the effort to develop a procedure for the separation of the optical isomeric forms of p-BPA for future application in melanoma BNCT); boron microscopic analytical development (analysis of SIMS images of boron-treated U-87 cells is complete and results will show cellular concentrations of B, K, Na, and Ca under different drug dosages); noninvasive boron quantification determination (optimization of pulse sequences for {sup 10}BSH MRI may result from the dissolving of double quantum coherence differences between {sup 10}BSH and {sup 11}BSH); and additional measurements have greatly narrowed the previously observed differences between calculated and measured total radiation doses in phantoms.

Research Organization:
EG and G Idaho, Inc., Idaho Falls, ID (United States)
Sponsoring Organization:
DOE/NE
DOE Contract Number:
AC07-76ID01570
OSTI ID:
7018387
Report Number(s):
EGG-BNCT-8353-Vol.3-No.9; ON: DE90007044
Country of Publication:
United States
Language:
English